Maia: Pioneering AI-Driven Surgical Assistance in Medicine

In the rapidly evolving landscape of healthcare technology, Medivis is at the forefront with its upcoming AI Agent, Maia. Designed as an intelligent assistant for clinical AI and translational research, Maia represents a significant leap in integrating artificial intelligence with augmented reality (AR) to enhance surgical precision and patient outcomes. As of January 2026, Maia remains in development, marked as “coming soon” on Medivis’s official platforms, with the company actively seeking collaborations for early access.

The Vision Behind Maia

Maia is powered by advancements in vision-language models and context engineering, enabling it to “see what you see” and comprehend user intent across complex medical workflows. This AI Agent is engineered to support tasks in medical imaging, surgical planning, and intra-operative navigation. Key capabilities include executing automatic and interactive segmentations of medical images, guiding instrument calibration and registration, and allowing dynamic control of visualizations through natural-language voice and text commands. By understanding software interfaces and user actions end-to-end, Maia aims to streamline operations in the operating room, reducing the cognitive load on surgeons and improving efficiency.

Medivis, a surgical intelligence company, integrates Maia into its flagship SurgicalAR platform. SurgicalAR transforms 2D medical scans—like CT and MRI—into high-fidelity 3D holographic visualizations that can be superimposed directly onto the patient’s body during procedures. This AR overlay provides surgeons with real-time, patient-specific anatomical insights, akin to enhanced vision without invasive measures.

Key Features and Capabilities

Maia’s design focuses on seamless integration into clinical environments, offering a range of features that leverage AI to augment human expertise:

Context-Aware Assistance: Maia interprets visual and contextual data from the surgical field, understanding user intent to automate routine tasks and provide proactive guidance.
Automated Segmentations: It performs precise, interactive segmentations of anatomical structures from imaging data, such as identifying vessels or tissues in CT scans. Visual demonstrations show Maia’s interface handling complex 3D renderings of cranial and vascular anatomy.
Instrument Guidance: The agent assists in calibrating and registering surgical tools within the AR space, ensuring accuracy during procedures.
Natural Language Interaction: Surgeons can control visualizations—rotating, cropping, or adjusting models—via voice or text, allowing hands-free operation in sterile environments.
Workflow Integration: Maia supports flexible integrations with intraoperative scanners, CT/MRI machines, and other medical devices, extending its utility from preoperative planning to bedside interventions.

These features build on Medivis’s existing innovations, such as automatic patient registration using facial capture, which aligns scans in seconds for immediate use.

Clinical Applications and Real-World Impact

While Maia is not yet commercially available, its potential applications draw from Medivis’s established SurgicalAR deployments and ongoing research. The platform has been piloted in settings such as the James A. Haley Veterans Hospital in Tampa, where it is transforming surgical precision.

Neurosurgery and Cranial Procedures: Maia’s imaging capabilities support high-accuracy guidance for cranial interventions. Visualizations of brain structures, ventricles, and vessels from CT/MRI scans enable precise navigation, potentially aiding procedures like craniotomies or external ventricular drain placements.
Spine Surgery: In both open and minimally invasive approaches, Maia assists with real-time visualization of screw placement, reducing risks and improving accuracy.
Preoperative Planning and Other Specialties: The agent facilitates immersive 3D strategies for complex reconstructions, such as flap procedures for wounds. Research explorations include applications in prostate biopsies and tumor ablations, though these remain investigational.
Bedside and ICU Interventions: By extending AR guidance beyond traditional ORs, Maia could enable precise procedures in non-sterile environments, broadening access to advanced care.

These applications align with broader trends in healthcare AI for 2026, where agents like Maia are expected to automate repetitive tasks and provide real-time decision support, synthesizing vast data for better outcomes. Deployments at institutions like the Tampa VA demonstrate reduced complications, faster procedures, and cost savings.

Development Status and Collaborations

Maia is currently in active development, with Medivis inviting partnerships from institutions, technology firms, and researchers to refine its capabilities. The company emphasizes ethical AI integration, focusing on improving patient outcomes through AR and AI synergy. As part of Medivis’s mission to make AR the standard of care, Maia positions itself as a transformative tool in surgical intelligence.

In summary, Maia embodies the next evolution in medical technology, blending AI’s analytical power with AR’s immersive visuals. While awaiting full release, its promise of enhanced surgical workflows and precision underscores Medivis’s commitment to advancing healthcare. Interested parties are encouraged to reach out for early access opportunities.